BiSpecifics PDF

Case Study: CRS and Efficacy using a BCMAxCD3 Bispecific Antibody

Case Study: Evaluation of Bispecific Antibody Efficacy and Drug-Induced Cytokine Release

Case Study: PK/PD, Safety, and Efficacy Platforms

Rapid Purification of Human Bispecific Antibodies via Selective Modulation of Protein A Binding

Methods to rapidly generate high quality bispecific antibodies (BsAb) having normal half-lives are critical for therapeutic programs. Here, we identify 3 mutations.